EXAGEN INC. Quarterly Operating Margin in % from Q4 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Exagen Inc. quarterly/annual Operating Margin history and growth rate from Q4 2019 to Q2 2024.
  • Exagen Inc. Operating Margin for the quarter ending June 30, 2024 was -27.9 %, a 57.7% increase year-over-year.
  • Exagen Inc. annual Operating Margin for 2023 was -43.5 %, a 57% increase from 2022.
  • Exagen Inc. annual Operating Margin for 2022 was -101 %, a 103% decline from 2021.
  • Exagen Inc. annual Operating Margin for 2021 was -49.8 %, a 37.7% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -27.9 +38.1 +57.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -32.5 +62.5 +65.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -43.5 +57.6 +57% Oct 1, 2023 Dec 31, 2023
Q3 2023 -62.3 +20.9 +25.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -66 +19 +22.4% Apr 1, 2023 Jun 30, 2023
Q1 2023 -95 -36.4 -62.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -101 -51.2 -103% Oct 1, 2022 Dec 31, 2022
Q3 2022 -83.3 -40.7 -95.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -85 -46.9 -123% Apr 1, 2022 Jun 30, 2022
Q1 2022 -58.6 -22.4 -62.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -49.8 -13.7 -37.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -42.6 -3.95 -10.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -38.2 -3.31 -9.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -36.1 -5.07 -16.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -36.2 -13.2 -57.1% Oct 1, 2020 Dec 31, 2020
Q3 2020 -38.7 Jul 1, 2020 Sep 30, 2020
Q2 2020 -34.8 Apr 1, 2020 Jun 30, 2020
Q1 2020 -31.1 Jan 1, 2020 Mar 31, 2020
Q4 2019 -23 Oct 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.